news and event

7.10.2007 TheraJect presented two posters (1st and 2nd) at the 34th CRS
Annual Meeting in Long Beach, California.

6.5.2007 TheraJect Chief Technical Officer Dr. Sung-Yun Kwon presented
TheraJect Interdermal Patch for Influenza at WHO Conference

5.1.2007 3 rd US patent (#7 ,2 11 ,0 62 ) was issued.

2.27.2007 2 nd US patent (#7 ,1 82 ,7 47 ) was issued.

10.30.2006 TheraJect p resented 1st pre-clinical data of Influenza vaccine
delivery in 2006 AAPS Annual Meeting in San Antonio, Texas.

7.24.2006 TheraJect presented at the 3 3 r d CRS Annual Meeting in V ienn a ,
A ustria .

7.19.2006 TheraJect is part of the Patterson HIV Vaccine Development
Consortium, which is funded by a grant from the Bill & Melinda Gates
Foundation.

7.15.2006 TheraJect was granted research fund from NIH/NIA for PTH
Delivery Research Program.

9.20.2005 1 st US patent (#6,945,952) is issued.

6.20.2005 TheraJect presented at the 32nd CRS Annual Meeting in Miami,
Florida.

6.5.2005 TheraJect presented at the 2005 AAPS National Biotechnology in
San Francisco, California.

10.26.2004 TheraJect was granted research fund from NIAID for Biodefense
Research Program.

6.15.2004 TheraJect presented at the 31st CRS Annual Meeting in Honolulu,
Hawaii.